About Us
Contact Us
Newsroom
Issue Areas
Artificial Intelligence
COVID-19
Health Equity, Diversity, & Inclusion
Reducing Health Costs
Health Care Reform
Value
Real-World Evidence
Patient Engagement
FDA Regulations
Medicaid Unwinding Resources
Resources
Member Resources
Fair-Market Value Calculator
Patient Experience Mapping
A Blueprint for Developing Patient-Centered Core Impact Sets (PC-CIS)
Trusted Messengers
Meetings & Events
Letters & Comments
Research Briefs
Job Bank
Education
Real-World Evidence Classroom
Value Classroom
Patient-Focused Medical Product Development Series
Clinical Outcome Assessment Series
Health Literacy Series
Health Care Quality
Webinars
Blog
Membership
Our Members
Standards of Excellence
CAE Approved Provider
Become a Member
Accessibility Tools
Toggle navigation
letters & comments
NHC Comments on Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies
03/04/2024
Read More
NHC Comments on Draft CY 2025 Part D Redesign Program Instructions
03/04/2024
Read More
NHC Statement on Artificial Intelligence and Health Care: Promise and Pitfalls
02/08/2024
Read More
NHC Comments on NIST Draft March-In Framework
02/06/2024
Read More
NHC’s Response to Bill Cassidy Gene Therapy RFI
01/22/2024
Read More
NHC’s Comments in response to the 2025 Notice of Benefit and Payment Parameters (NBPP)
01/10/2024
Read More
NHC Comments on Senate Finance Telehealth Hearing
11/28/2023
Read More
NHC Comments on Notice of Proposed Rulemaking on Discrimination on the Basis of Disability in Health and Human Service Programs or Activities
11/14/2023
Read More
NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program
11/14/2023
Read More
« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next »
